CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective

Journal of NeuroInterventional Surgery

Volumn 4, Issue 4, 2012, Pages 261-265

  Turk, Aquilla ^a   Magarik, Jordan Asher ^a   Chaudry, Imran ^a   Turner, Raymond D ^a   Nicholas, Joyce ^a   Holmstedt, Christine A ^a   Chalela, Julio ^a   Hays, Angela ^a   Lazaridis, Christos ^a   Jauch, Edward ^a   Chimowitz, Marc ^a   Turan, Tanya ^a   Adams, Robert ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN RADIOGRAPHY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROIMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RANKIN SCALE; RECANALIZATION; REPERFUSION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

AGED; BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PERFUSION IMAGING; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84863003253     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010067     Document Type: Article

References (36)

1. Anon. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and stroke rt-PA stroke study group. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
3. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-41.
4. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
5. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127-35.
6. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
7. Lin R, Vora N, Zaidi S, et al. Mechanical approaches combined with intra-arterial pharmacological therapy are associated with higher recanalization rates than either intervention alone in revascularization of acute carotid terminus occlusion. Stroke 2009;40:2092-7.
8. Shi ZS, Loh Y, Walker G, et al. Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: Pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and multi MERCI trials. Stroke 2010;41:953-60.
9. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
10. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711. (Pubitemid 46691097)
11. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010;41:1996-2000.
12. Schellinger PD, Thomalla G, Fiehler J, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007;38:2640-4.
13. Kohrmann M, Juttler E, Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006;5:661-7. (Pubitemid 44062409)
14. Koenig M, Kraus M, Theek C, et al. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001;32:431-7. (Pubitemid 32155230)
15. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-85.
16. Wintermark M, Rowley HA, Lev MH. Acute stroke triage to intravenous thrombolysis and other therapies with advanced ct or MR imaging: pro CT. Radiology 2009;251:619-26.
17. Ledezma CJ, Wintermark M. Multimodal CT in stroke imaging: new concepts. Radiol Clin North Am 2009;47:109-16.
18. Ezzeddine MA, Lev MH, McDonald CT, et al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke 2002;33:959-66. (Pubitemid 34293575)
19. Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021-8.
20. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004;35:-27-9.
21. Christou I, Felberg RA, Demchuk AM, et al. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 2002;12:119-23. (Pubitemid 34252426)
22. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
23. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
24. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003;34:575-83.
25. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
26. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Aspects study group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
27. Rowley HA, Roberts TP. Clinical perspectives in perfusion: neuroradiologic applications. Top Magn Reson Imaging 2004;15:28-40. (Pubitemid 38437543)
28. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase In Acute ischemic Stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73. (Pubitemid 40054177)
29. Lansberg MG, Thijs VN, Hamilton S, et al. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in defuse. Stroke 2007;38:1826-30. (Pubitemid 46847254)
30. De Silva DA, Brekenfeld C, Ebinger M, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010;41:295-9.
31. Natarajan SK, Snyder KV, Siddiqui AH, et al. Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009;40:3269-74.
32. Juttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007;38:2518-25. (Pubitemid 47329631)
33. Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for spaceoccupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with Life-Threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009;8:326-33.
34. Shi ZS, Loh Y, Walker G, et al. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusion. Stroke 2010;41:1185-92.
35. The Penumbra Pivotol Stroke Trial Investigators. The Penumbra pivotol stroke trial. Stroke 2009;40:2761-8.
36. DeGraba T, Hallenbeck J, Pettigrew K, et al. Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999;30:1208-12. (Pubitemid 29259175)